[Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
Marín
R
R
Servicio de Nefrología, Hospital Universitario Central de Asturias, Celestino Villamil, s/n 33006 Oviedo, Asturias. rmarini@hca.es
Goicoechea
M A
MA
Gorostidi
M
M
Cases
A
A
Díez
J
J
Escolar
G
G
Fernández-Vega
F
F
Palomar
R
R
Rodrigo
E
E
Martínez
I
I
Segura
J
J
D000465:Algorithms; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control; D019090:Case Management; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D015897:Comorbidity; D004198:Disease Susceptibility; D006306:Health Surveys; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000453:epidemiology; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D007677:Kidney Function Tests; D016030:Kidney Transplantation; D009398:Nephrology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D006435:Renal Dialysis; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors; D012955:Societies, Medical; D013030:Spain
D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors